Potentialization of isoniazide by DIMETHYLSUPHOXIDE (DMSO) in the treatment of hamsters (Mesocricetus auratus), experimentally infected with Mycobacterium bovis (AN5).

Authors

  • Antonio Carlos Paes
  • José de Angelis Cortês

DOI:

https://doi.org/10.35172/rvz.2008.v15.394

Keywords:

tuberculosis, Mycobacterium bovis, Mesocricetus auratus, isoniazide, dimethylsulphoxide

Abstract

Zoonotic tuberculosis is a worldwide disease with a high importance to public health, caused by bacterium Mycobacterium bovis. Its resistance to some drugs is very discussed based in the treatment and diagnosis of M.bovis. Thus, we aimed to verify the potentiality effect of dimethylsulphoxide (DMSO) compared to isoniazide. Three groups of 20 hamsters each one were experimentally inoculated with a M.bovis strain: G1, control; G2, treated with isoniazide, during 30 days after the infection; G3, with isoniazide associated with DMSO, for the same period. All groups were sacrificed at the final of the experiment. At the necropsy, liver, lung, spleen and kidney of all the animals were collected for histopathological test, to evaluate the intensity of the lesions; morphometric analysis of granulomes; and microbiological tests to isolate and quantification of the agent. The histopathological results revealed lower intensity of the lesions, and lower number of granulomes and of the occupied area for these one in liver and lung of animals of G3 than other groups. Microbiological test revealed a decrease in the quantity of the agent in studied organs, in G3, with statistical difference, compared to G2. Thus, the results confirmed the efficacy of DMSO to enhance the therapeutic action of isoniazide against a M.bovis pathogenic strain, probably by the increasing of its penetration into tuberculous lesions and by the complex cellular wall of the agent, however, not enough to the completely elimination of the infection.

References

BEER, J. Enfermedades infecciosas de los animales domésticos. Zaragoza: Editorial Acribia, 1981, 2, 347p.
BLOOD, D.C., RADOSTITIS, O.M., GAY, C.C. Veterinary Medicine. London: Bailliere Tindal, 1994, 1763p.
CORREA, W.M., CORREA, C.N.M. Enfermidades Infecciosas dos Mamíferos Domésticos. Rio de Janeiro: MEDSI Editora Médica e Científica, 1992, 843p.
CURI, P.R. Metodologia e Análise da Pesquisa em Ciências Biológicas. Botucatu: Tipomic, 1997, 263p.
FERREIRA NETO, J. S.; PINHEIRO, S. R.; MORAIS, Z. M.; SINHORINI, I. L.; ITO, F. H.;
VASCONCELLOS, S. A. Avaliação quantitativa da concentração de micobactérias em órgãos e humores de hamsters experimentalmente infectados com Mycobacterium bovis, estirpe AN5. Brazilian Journal Veterinary Research and Animal Science, v. 31, p. 131-139, 1994.
FERREIRA NETO, J. S.; PINHEIRO, S. R.; MORAIS, Z. M.; SÁ ROCHA, L. C.; SINHORINI, I. L.;
ITO, F. H.; VASCONCELLOS, S. A. Quantitative evaluation of the tuberculosis evolution in hamsters submitted to na eight-week trichlorfon treatment and infected with Mycobacterium bovis, strain AN5. Brazilian Journal Veterinary Research and Animal Science, v. 33, n. 3, 1996.
GRANGE, J.M. The mycobacteria. In: PARKER, M.T., DVERDEN, B.L. Eds. Topley & Wilson’s Principles of Bacteriology, Virology and Immunity. Philadelphia: B.C.Decker, 1990, 709p.
HIRATA, R.O.C. et al. Aplicação de técnicas de biologia molecular na avaliação da resistência de Mycobacterium tuberculosis à drogas antimicrobianas. Rev. Ci. Farmacol. S. Paulo, v.18, p.87-100, 1997.
JONES, T.C., HUNT, R.D. Veterinary Pathology. Philadelphia: Lea Febiger, 1983, 1792p.

MANDELL, G.L., PETRI JR., W.A. Drugs used in the chemotherapy of tuberculosis, Mycobacterium avium complex disease and leprosy. In: HARDMAN, J.G., LIMBIRD, L.E. Eds. Goodman & Gilman’s The pharmacological basis of therapeutics. New York: McGraw-Hill, 1996, p.1155-1174.
MARIANO, M. The experimental granuloma. A hypothesis to explain the persistence of the lesion.
Rev. Inst. Med. Trop. S. Paulo, v.37, p.161-176, 1995.
NEILL, D. et al. Bovine tuberculosis – Pathogenesis of Mycobacterium bovis infection in cattle. Vet. Microbiol., v.40, p.41-52, 1994.

PAES, A.C. Redução do período de tratamento da tuberculose bovina com associação de estreptomicina, isoniazida e dimetil sulfóxido. Botucatu, 1990, 33p. Dissertação (Mestrado) – Faculdade de Medicina Veterinária e Zootecnia, Universidade Estadual Paulista “Julio de Mesquita Filho”.

PALERMO-NETO, J.; SANTOS, G. O.; GUERRA, J. L.; PINHEIRO, S. R. Glue solvent inhalation
impairs host resistance to Mycobacterium bovis – induced infection in hamsters. Veterinary and Human Toxicology, v. 43, n. 1, p. 1-5, 2001.
TAVARES, W. Manual de Antibióticos e Quimioterápicos Antiinfecciosos. São Paulo: Ateneu, 1996, 792p.
UGAZ, E. M. A.; PALERMO NETO, J.; PINHEIRO, S. R.; GUERRA, J. L. Effects of prenatal
diazepam treatment on Mycobacterium bovis –induced infection in hamsters. Immunopharmacology, v. 41, p. 209-217, 1999.
YOUMANS, G.P. Tuberculosis. Philadelphia: W.B.Saunders, 1979, 511p.

Published

2008-09-30

How to Cite

1.
Paes AC, de Angelis Cortês J. Potentialization of isoniazide by DIMETHYLSUPHOXIDE (DMSO) in the treatment of hamsters (Mesocricetus auratus), experimentally infected with Mycobacterium bovis (AN5). RVZ [Internet]. 2008 Sep. 30 [cited 2024 May 15];15(3):486-95. Available from: https://rvz.emnuvens.com.br/rvz/article/view/394

Issue

Section

Original Articles

Most read articles by the same author(s)

<< < 1 2